1. MENTAL HEALTH PROBLEMS AMONG SEXUAL MINORITY GROUP WITH HIV
Erdenechimeg R ; Khihigzuren Z ; Jargal B ; Tungalag M ; Davaalkham J
Innovation 2015;9(1):76-80
There were currently diagnosed by totally 177 cases with HIV in our country. The 82.3% of those were male and 72.9% of them were men sex with man. Sexual minority group especially men who intercourse with male are highly risk to HIV infection. By the study of 2011, which aimedto assess risk to exposure HIV infection among sexual minority group, 56.2% of all participants answered as had depression symptoms and 12.8% of them seen to psychologist and health workers. In addition, 2% of them used by injection of drug for last year, and 60.6% harmfully drank.The study was done by quantitative and qualitative methods and used specific designed questionnaire for sexual minority with HIV infection. Totally 26 consumers participated in our survey. Before the starting of the study, we introduced inform consent to all participants and if they agreed to participate, we coded research cards and collected the information.All participants were answered alcohol drink, and 46.1% of them determined with heavy drinking or harmful consumption by the AUDIT versus 7.8% were alcohol dependence. 65.3% oftotal participants used as smoke, 5 cases used cannabis; one of them has been used within last twelve months. In addition, 23.1% of all participants had anxiety and 15.3% had mild depression symptoms. Of the total 26 cases, 7 cases had suicide thinking related with sexual orientationand 2 cases had suicide thinking related with HIV infection. Those cases answered often feeling hopeless and helpless.In sexual minority group with HIV, alcohol and tobacco consumption was high, drug abuse was low. 15.3-23.1% of all participants had depression and anxiety symptoms. Suicide thinking has been occurred for those cases it means risk to suicide commitment.
2. SCREENING THE NEWBORN FOR DYSPLASIA OF THE HIP
Tungalag L ; Bilegjargal CH ; Uranchimeg D ; Ariunjargal B
Innovation 2015;9(3):55-56
Developmental Dysplasia of the Hip (DDH) is a major health problem which can lead to lifelong handicapped condition of individuals if early diagnosis is missed. Cost for treatment, surgery and rehabilitation of these cases is much higher than that for prevention. According to Graf, hip ultrasound screening method is simple, reproducible, innocuous and can be performed by well- trained neonatologists. The purpose of this study is to determine prevalence and types of hip dysplasia by Graf standard screening method. A prospective study was carried out. Hip ultrasound screening using Graf method was performed by neonatologists at the Amgalan of maternity of the Capital city from January 2013 to March 2015.Totally 6154 neonates were eligible for the study and 50.9% of them were male, 93.27% term and 6.72% preterm, in 8.53% of babies, type IIa (physiological retardation of ossification)was found. Dysplasia or dislocation of hips (type III and IV) was found in 5 (0.08%) neonates. Babies diagnosed with type I on both hips were discharged. Type IIa cases were stopped being swaddled and reassessed after 4 weeks. Cases with type III and IV cases were all treated with abduction treatment or Tubinger. This study is an ongoing project. The implementation of the hip ultrasound screening according to Graf is feasible and can be performed by well-trained neonalogists in Amgalan of maternity of the Capital city.
3. STUDY OF GLUCOSE-6-PHOSPATE DEHYDROGENASE IN HEALTH NEONATES
Khishigjargal B ; Gereltuya Y ; Gerelmaa N ; Tungalag L ; Gerelmaa Z ; Erdenetuya G
Innovation 2015;9(4):56-58
Glucose-6-phosphatase dehydrogenase (G6PD) deficiency is the most common enzyme deficiency in humans, affecting 400 million people worldwide and a high prevalence in persons of African, Middle Asian countries. The most common clinical manifestations are neonatal jaundice and acute hemolytic anemia, which is caused by the impairment of erythrocyte’s ability to remove harmful oxidative stress triggered by exogenous agents such as drugs, infection, or fava bean ingestion. Neonatal hyperbilirubinemia caused by glucose-6-phosphate dehydrogenase (G6PD) is strongly associated with mortality and long-term neurodevelopmental impairment. Aim:To determine a level of glucose-6-phosphate dehydrogenase in healthy neonates.The 76.5% of all participants (n=205) was assessed 4.36±1.15 Ug/Hb in normal reference range of G6PD other 23.5% (n=63) was 0.96±0.51 Ug/Hb with G6PD deficiency. In the both sex, 51.5% of male 0.88±0.46Ug/Hb (n=33) and 47.6%of female (n=30) 0.97±0.55Ug/Hb was assessed with G6PDdeficiency. Developing Jaundice period in number of 63 neonates with G6PD deficiency, 85.7% of neonates (n=54)was in 24-72 hours, 4% of neonates (n=3) was in 5-7 days and there is no sign of jaundice in 9% (n=6).Therefore neonates with G6PD deficiency, 53.9% (n=34)contiuned jaundice more than two weeks.G6PD deficiency was determined in male neonates (51.5%) more than female(47.6%). The 76.5% of all participants (n=205) was assessed 4.36±1.15 Ug/Hb in normal reference range of G6PD other 23.5% (n=63) of all participants was 0.96±0.51 Ug/Hb with G6PD deficiency. It shows that G6PD might be one potential risk of neonatal jaundice and hyperbilirubinemia in neonates in Mongolia.
4.Trends of health care professionals toward adverse drug reaction reporting
Narankhuu E ; Erdenetuya M ; Purevsuren S ; Baysgalan B ; Sarnaizul E ; Tungalag B
Mongolian Medical Sciences 2013;164(2):59-62
IntroductionThe detection of adverse drug reactions has become increasingly significant because of introduction of a large number of potent toxic chemicals as drugs in the last two or three decades. Adverse drug reaction (ADR) monitoring and reporting activity is in its infancy in Mongolia. The important reason is lack of awareness and lack of interest of healthcare professionals in ADR reporting and documentation.GoalTo evaluate implementation and trends of health care professionals toward adverse drug reaction reporting at first, second and tertiary level hospitals.Materials and MethodA prospective study was carried out in first and second level hospitals of Khentii, Dundgovi, GoviAltai, Selenge and Uvurkhangai provinces, Sukhbaatar, Songinokhairkhan district hospital and First maternaty hospital. From tertiary level hospitals were selected First national hospital, Third national hospital, National center of oncolgy, National center of traumatolgy. The questionnaire survey involved total of 175 doctors and pharmacists.ResultsThe study result have shown that most of health care profeesionals (76 – 80%) of first and tertiary level hospitals have known about legal bases and theie duties for the ADR reporting than health care professionals (69%) of secondary level hospitals. And, pharmacists more activily involve in ADR reporting than doctors. The main reasons of healthcare professionals ADR underreporting were lack of time to report, lack of awarness about ADR and not knowing importance of ADR repoting. The implementetion extent of ADR reporting was in tertiary level hospital better than in secondary level hospitals. Lacking of clinical pharmacists and clinical pharmacologists and unproper activitity of Drug therapeutic committee in secondary level hospitals were the reason of poor implementing and underreporting of ADR.ConclusionThe study result has shown that there is needed to encourage doctors to the adverse drug reporting activity and implementation of drug safety should be strengthen in each level of health care system.
5.НАТРИ ХӨӨГЧ ПЕПТИД БА ЗҮРХНИЙ АРХАГ ДУТАГДЛЫН ЗАРИМ ЭРСДЭЛТ ХҮЧИН ЗҮЙЛСИЙН ХАМААРАЛ
Batdelger T ; Chingerel KH ; Tsolmon U ; Tungalag Sh ; Dulamkhand B
Innovation 2017;11(2):19-21
BACKGROUND. Heart failure is the leading cause of the death among non-communicable
diseases. Heart failure is a fatal disease that once its clinical symptoms appeared,
five years of survival rate is 50-75%. Chronic heart failures are the main risk factors arterial
hypertension, diabetes, obesity and dyslipidemia Thus, early diagnosis before its symptoms
are presented and treatment with close monitoring is the most rational and effective
approach for decreasing heart failure diseases and deaths caused by it.
OBJECTIVE. To determine the level of NT-pro BNP in people with high risk of chronic
heart failure and assess its results. METHODS. We conducted hospital-based descriptive
study at State Second Central Hospital and Bayanzurkh District Medical Center. Total of
100 participants aged from 35 to 64 who had no symptom of chronic heart failure however
with high risk were recruited in this study. Based on the document entitled “Heart
failure prevention 2008” of the American Heart Association, old age, arterial hypertension,
diabetes mellitus, heart attack and obesity were considered as higher risks of heart
failure. Risk factors of heart failure were estimated by questionnaire and physical examination.
The level of NT-pro BNP in plasma was determined using FIA8000 analyzer.
According to the guideline produced by the European Society of Cardiology in 2016,
result of the testing is considered “positive” when NT-pro BNP is higher than 125 pg/ml.
Risk factors of chronic heart failure were studied in comparison with two groups which
were NT-pro BNP positive and negative results and their statistically significant difference
were determined. RESULTS. Of 87 participants, 51 (51%) were female and 49(49%) were
male. Half of the participants (51%) were aged between 55-64. Arterial hypertension
was determined in 88% of the participant, 38% were overdose drink of alcohol, therefore
55% were 1,2,3 levels obesity and 36% were diabetic. When determining the NT-pro BNP
level, in 34 cases (34%) were positive. Hence, 31% of the people with arterial hypertension,
9% of the people overdose drink with alcohol, 20% of the people with obesity, 12%
of the people with diabetes showed positive results of NT-pro BNP. When studying the
risk factors of chronic heart failure of the compared two groups of NT-pro BNP positive
and negative results, statistically significant difference (p<0.05) was increased of the
with arterial hypertension and obesity. CONCLUSION. NT-pro BNP is the arterial hypertension
and obesity which is increasing for people compared to the other risking factors
6.Food poisoning infection caused by Salmonella spp
Tungalag O ; Enerel E ; Dagvadorj Ts ; Narangerel B ; Lkhagvadorj D ; Altantsetseg D
Mongolian Medical Sciences 2019;190(4):3-7
Background:
We aimed to study the etiology and transmission route of diseases introducing the modern, rapid and
high-sensitivity molecular genetic diagnostic methods for salmonellosis.
Material and Method:
In the study, we collected 680 stool samples and defined organisms of food intoxication by identification
of bacteria, polymerase chain reaction (PCR) and determined serotype and antibiotic resistance.
Result:
Salmonella spp was detected from the stool of 25 (42.3%) patients out of 59 outpatient clinic and
of 170 (27.4%) patients out of 621 inpatient clinic with diagnosis of food intoxication. In total there
was detected 195 salmonella spp, and out of this isolated Sal. typhimurum in 193 (98.9%), and Sal.
enteritidis was in 2 (1.1%) patients, respectively. We defined Sal. typhimurum in selected 32 cultures
and did not detect resistant gene DT-104 ACS-SuT by PCR.
Conclusion
As resulted in the survey, we defined 195 (28,6) Salmonella typhimurum among the 680 patients who
were suffered from food intoxication, and revealed fast foods, animal derived foods such as chicken,
fish caused the food intoxication. Sal. typhimurium not resistance to antibiotics.
7.THE RELATIONSHIP BETWEEN ATHEROGENIC INDEX OF PLASMA AND RISKS OF CARDIOVASCULAR DISEASE
Rinchyenkhand M ; Tungalag Sh ; Sarantsetseg S ; Odgerel N ; Burmaa B ; Tsolmon U
Innovation 2017;11(4):27-31
BACKGROUND: Cardiovascular diseases (CVDs) account for >17 million deaths globally each year and this figure is expected to grow to 23.6 million by 2030. According to the WHO report, one-third of ischemic heart disease is attributable to high cholesterol. There have been some claims that the atherogenic index of plasma (AIP), which is the logarithmic transformation of the just-mentioned ratio (TG/HDL-C), could be used as a significant predictor of atherosclerosis, and CVD as well. Thus, we aimed to study the relationship between AIP and cardiovascular risk factors.
METHODS: The cross-sectional hospital based study was conducted including 117 participants aged between 40-72 years old without cardiovascular symptoms were recruited from Second General Hospital. After filled consent form, participants’ habits of smoking, alcohol usage, obesity, arterial hypertension and sedentary lifestyle were assessed through a structured questionnaire and physical examination. By using fully automated open-system analyzer, determinations of total cholesterol, triglycerides, low-density lipoprotein (LDL-C), high-density lipoprotein (HDL-C) three times and glucose twice were performed simultaneously and then their averages were calculated. At least one abnormal lipid level was considered as “dyslipidemia”. The atherogenic index of plasma (AIP) was calculated as the logarithmically transformed ratio of molar concentrations of TG to HDL-C. Statistical analysis was performed using SPSS 22.
RESULTS: Of total 117 participants ranging 40-72 years old, 45.3% were male and 54.7% were female with mean age 53.6±0.79. Regarding cardiovascular risk factors, 63.8% were physically inactive, 32.48% were smokers, 47% were alcohol user, 48% were hypertensive, and 18.26% were diabetic. The mean values plus standard error of lipid components were 195.5±6.09 mg/dL in cholesterol, 181.25±27.36 mg/dL in triglycerides, 60.6±1.39 mg/dL in HDL-C, 138.5±3.74 mg/dL in LDL-C, 6.27±0.26 mmol/L in fasting glucose. The dyslipidemia was detected in 54.7% of total participants and mean level of AIP was 0.33±0.03 (min=-0.52; max=1.51). The mean levels of 10 year and lifetime risk were 6.25±0.63% (min=0.2; max=33.5) and 43±1.53% (min=7.5; max=69), respectively. AIP had weak correlations with gender, smoking, anti-hypertensive drug usage, aspirin usage, 10 year and lifetime risks of CVD, hypertension, fasting glucose, body mass index, and dyslipidemia (0.2